Ann: Voluntary Suspension, page-148

yeah that's my problem with it as well. Applying the market average P/E of 15 to this company means they are already priced with the expectation of a stable $15 million in profit per annum and pay a dividend. A LOT of upside is already priced in. If the results aren't good enough for the FDA then this puppy goes back to a valuation of cash in the bank. That is a lot of downside risk.

But good luck to the true believers. It's possible they are right and this is the next big thing that will be worth billions of dollars. But it's time for management to deliver on their promises - let's see what happens.